AEGiS-SFE: Study offers new tools in fight against HIV: UCSF scientist finds weak, potent antiviral factors San Francisco ExaminerImportant note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


Study offers new tools in fight against HIV: UCSF scientist finds weak, potent antiviral factors

San Francisco Examiner - April 13, 2005
Marisa Lagos, mlagos@examiner.com


A study published today by UC San Francisco's Dr. Warner Greene may lead to new therapies for HIV and AIDS.

Dr. Greene, director of the UCSF-affiliated Gladstone Institute of Virology and Immunology, and his laboratory discovered why some CD4 T-cells - the main target of HIV - are able to fend off the virus, while others are essentially destroyed by it.

The reason, according to the study published Wednesday in the online version of Nature, is that a form of a potent antiviral factor exists in resting T-cells, allowing them to fight off HIV. A larger, ineffective form of the antiviral factor exists in activated T-cells, where HIV wreaks havoc.

In an interview from Canada, where he is attending an HIV/AIDS conference, Greene said the knowledge could lend itself to new therapies and strategies for preventing the spread of HIV infection in the human body.

"I think it gives us a brand new perspective," said Greene. "It completely changes way we look at the whole problem ... when you realize resting T-cells have figured out a way to be completely resistant to HIV. If we can find out a way to [mimic that], we'll really be in business."


050413
SE050402


Copyright © 2005 - San Francisco Examiner. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Examiner, Permissions Desk, 110 Fifth Street, P.O. Box 7260, San Franciso, CA 94120.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .